Evidence map›Paper›PMID 41659876›Full record

ArticleFrontiers in immunology2026

Correction: Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis.

Minyan Ye, Yinuo Dong, Xiaoyun Li, Yang Zhi, Yuping Lu, Jieting Tang, Wei Zhong, Xiaohong Lei, Yimin Mao, Sha Huang and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Minyan YeDepartment of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Yinuo DongDivision of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xiaoyun LiDivision of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yang ZhiDivision of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yuping LuDepartment of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Jieting TangDivision of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wei ZhongDivision of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xiaohong LeiDivision of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yimin MaoDivision of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sha HuangDepartment of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Yanyan SongDepartment of Biostatistics, Clinical Research Institute, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1677998.].

Indexed as

advanced effectimmunotherapyLAG-3meta - analysissafetyTIGIT

Identifiers

PMID41659876
PMCPMC12873477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.